From IMDC Risk Assessments to Sequencing Strategies: Clinical Implications From CLEAR Post Hoc Analyses

Experts discuss the clinical implications from CLEAR post hoc analyses, focusing on IMDC risk assessments and sequencing strategies.

EP: 1.CLEAR Trial Insights on Lenvatinib Plus Pembrolizumab: Depth of Response and Clinical Outcomes in Advanced RCC

EP: 2.Tumor Burden Impact on Postprogression Survival: Optimizing Strategies for Maximum Response in RCC

EP: 3.From Initial Response to Long-Term Outcomes: Optimizing RCC Treatment Strategies Across the Care Continuum

Now Viewing

EP: 4.From IMDC Risk Assessments to Sequencing Strategies: Clinical Implications From CLEAR Post Hoc Analyses

Recent Videos